CPT code 83789 designates the technical laboratory procedure for detecting or quantifying a nondrug analyte using mass spectrometry and tandem mass spectrometry. As an advanced clinical laboratory service, it supports diagnostic workflows across specialties that require precise measurement of biochemical markers, toxicology screens, metabolic testing, and other nonpharmaceutical analytes. Nationally, codes like 83789 matter because they underpin access to specialized testing, drive laboratory billing practices, and inform payer coverage and reimbursement policies for high-complexity assays.

Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, the clinical and laboratory context for use, typical sites of service, and which major payers are relevant to coverage discussions. The publication also summarizes available benchmarks and policy considerations for mass spectrometry–based nondrug analyte testing where data is available. Where specific input data is missing, the text notes that those items are not available in the input rather than inferring details.

This executive summary prepares clinicians, laboratory managers, and policy analysts to interpret billing practices related to 83789, understand payer relevance at a national level, and locate further detail on technical, clinical, and administrative aspects of mass spectrometry laboratory services.